Skip to main content
NCBI home page
Journal of the American Aging Association logoLink to Journal of the American Aging Association
. 2001 Jan;24(1):1–10. doi: 10.1007/s11357-001-0001-9

Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review

Qi-Wen Fan 1, Ichiro Iosbe 1, Hiroaki Asou 2, Katsuhiko Yanagisawa 1, Makoto Michikawa 1,✉
PMCID: PMC3455648  PMID: 23604870

Abstract

The importance of apolipoprotein E (apoE) in the central nervous system (CNS) became increasingly clear since the descovery that apoE ε4 allele is a major risk factor for Alzheimer’s disease. ApoE is one of the major apolipoproteins that acts as a ligand for the cellular uptake of lipoproteins via apoE receptors, members of low-density lipoprotein receptor (LDLR) family, in the CNS. Recently, LDLR family has been shown to have new functions that modulate intracellular signalling and affect neuronal and glial functions, survival and regeneration. However, the pattern of expression of apoE receptors in the CNS has not been fully clarified yet. The LDLR, very low density lipoprotein receptor (VLDLR), LDLR-related protein (LRP), and apolipoprotein E receptor 2 (apoER2) are known to bind to and internalize apoE-containing lipoproteins. Here we summarize the expression of apoE receptors in the CNS and demonstrate additional our original data on cell type specific expression and regulation of those receptors in the CNS, using in situ hybridization and RT-PCR. The cells used in our study were highly enriched cultures of neurons, astrocytes, microglia and oligodendrocytes isolated from rat brain and neuroblastoma cell line, Neuro2a. All of these four types of receptors were shown to be expressed in neurons, astrocytes, microglia and oligodendrocytes, while LDLR and LRP were expressed in Neuro2a cells. We further examined the regulation of the expression of these receptors by altering the cholesterol content of the cells, and found that only the LDLR expression was downregulated following internalization of lipoprotein cholesterol and upregulated by cholesterol deprivation, in neuronal and astroglial cells. These data together with previous studies suggest that LDLR, VLDL, LRP, and apoER2 may be involved in apoE-mediated lipid uptake and/or intracellualr signalling in the cells of the CNS cells, i.e., neurons, astrocytes, microglia, and oligodendrocytes.

Full Text

The Full Text of this article is available as a PDF (3.2 MB).

References

  • 1.Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–30. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  • 2.Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res. Mol. Brain Res. 1991;11:97–106. doi: 10.1016/0169-328X(91)90111-A. [DOI] [PubMed] [Google Scholar]
  • 3.Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 1993;55:81–90. doi: 10.1016/0306-4522(93)90456-P. [DOI] [PubMed] [Google Scholar]
  • 4.Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1993;90:1977–81. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–3. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  • 6.Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet. 1993;342:697–9. doi: 10.1016/0140-6736(93)91705-Q. [DOI] [PubMed] [Google Scholar]
  • 7.Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43:1467–72. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  • 8.Michikawa M., Yanagisawa K. Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. J. Neurosci. Res. 1998;54:58–67. doi: 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  • 9.Michikawa M., Yanagisawa K. Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. Mech. Ageing Dev. 1999;107:233–43. doi: 10.1016/S0047-6374(98)00134-1. [DOI] [PubMed] [Google Scholar]
  • 10.Michikawa M., Fan Q.-W., Isobe I., Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 2000;74:1008–1016. doi: 10.1046/j.1471-4159.2000.0741008.x. [DOI] [PubMed] [Google Scholar]
  • 11.Michikawa, M., and Yanagisawa, K.: Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. J. Neurochem., 72, s2278–2285, 1999. [DOI] [PubMed]
  • 12.Yamamoto T., Davis C.G., Brown M.S., Schneider W.J., Casey M.L., Goldstein J.L., Russell D.W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984;39:27–38. doi: 10.1016/0092-8674(84)90188-0. [DOI] [PubMed] [Google Scholar]
  • 13.Herz J., Hamann U., Rogne S., Myklebost O., Gausepohl H., Stanley K.K. Surface location and high affinity for calcium of a 500-kDa liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 1988;7:4119–27. doi: 10.1002/j.1460-2075.1988.tb03306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bujo H., Hermann M., Kaderli M.O., Jacobsen L., Sugawara S., Nimpf J., Yamamoto T., Schneider W.J. Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family. EMBO J. 1994;13:5165–75. doi: 10.1002/j.1460-2075.1994.tb06847.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kerjaschki D., Farquhar M.G. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc. Natl. Acad. Sci. USA. 1982;79:5557–81. doi: 10.1073/pnas.79.18.5557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kim D.H., Iijima H., Goto K., Sakai J., Ishii H., Kim H.J., Suzuki H., Kondo H., Saeki S., Yamamoto T. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 1996;271:8373–80. doi: 10.1074/jbc.271.14.8373. [DOI] [PubMed] [Google Scholar]
  • 17.Beffert U., Danik M., Krzywkowski P., Ramassamy C., Berrada F., Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease. Brain Res. Brain Res. Rev. 1998;27:119–42. doi: 10.1016/S0165-0173(98)00008-3. [DOI] [PubMed] [Google Scholar]
  • 18.Willnow T.E., Nykjaer A., Herx J. Lipoprotein receptors: new roles for ancient proteins. Nat. Cell Biol. 1999;1:E157–E162. doi: 10.1038/14109. [DOI] [PubMed] [Google Scholar]
  • 19.Ikeda K., Aizawa T., Haga S., Otuska M., Mizuguchi M., Namba Y., Machinami R., Kim S.U., Yamamoto T. Very low density lipoprotein receptor and Alzheimer’s disease. In: Roses A., Weisgraber K.H., Cristen Y., editors. Apolipoprotein E and Alzheimer’s disease. Heiderberg: Springer-Vertag; 1996. pp. 74–96. [Google Scholar]
  • 20.Bu, G., Maksymovitch, E.A., Nerbonne, J.M., and Schwartz, A.L.: Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem., 269:18521–8, 1994. [PubMed]
  • 21.Ishiguro M., Imai Y., Kohsaka S. Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain Res. Mol. Brain Res. 1995;33:37–46. doi: 10.1016/0169-328X(95)00104-Z. [DOI] [PubMed] [Google Scholar]
  • 22.Jung-Testas I., Weintraub H., Dupuis D., Eychenne B., Baulieu E.E., Robel P. Low density lipoprotein-receptors in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 1992;42:597–605. doi: 10.1016/0960-0760(92)90450-W. [DOI] [PubMed] [Google Scholar]
  • 23.Zheng G., Bachinsky D.R., Stamenkovic I., Strickland D.K., Brown D., Andres G., McCluskey R.T. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpa 2MR, and the receptor-associated protein (RAP) J. Histochem. Cytochem. 1994;42:531–42. doi: 10.1177/42.4.7510321. [DOI] [PubMed] [Google Scholar]
  • 24.Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 1987;917:148–61. doi: 10.1016/0005-2760(87)90295-5. [DOI] [PubMed] [Google Scholar]
  • 25.Jordan C.A., Watkins B.A., Kufta C., Dubois-Dalcq M. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol. 1991;65:736–42. doi: 10.1128/jvi.65.2.736-742.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Christie R.H., Chung H., Rebeck G.W., Strickland D., Hyman B.T. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 1996;55:491–8. doi: 10.1097/00005072-199604000-00012. [DOI] [PubMed] [Google Scholar]
  • 27.Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G., Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 1995;92:9480–4. doi: 10.1073/pnas.92.21.9480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fagan, A.M., Bu, G., Sun, Y., Daugherty, A., and Holtzman, D.M.: Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem., 271:30121–5, 1996. [DOI] [PubMed]
  • 29.Narita M., Bu G., Holtzman D.M., Schwartz A.L. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 1997;68:587–95. doi: 10.1046/j.1471-4159.1997.68020587.x. [DOI] [PubMed] [Google Scholar]
  • 30.Willnow T.E., Rohlmann A., Horton J., Otani H., Braun J.R., Hammer R.E., Herz J. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 1996;15:2632–9. [PMC free article] [PubMed] [Google Scholar]
  • 31.Bu G., Geuze H.J., Strous G.J., Schwartz A.L. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 1995;14:2269–80. doi: 10.1002/j.1460-2075.1995.tb07221.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ji, Z.S., Pitas, R.E., and Mahley, R.W. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than ε4. J. Biol. Chem., 273:13452–60, 1998. [DOI] [PubMed]
  • 33.Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 1990;343:425–30. doi: 10.1038/343425a0. [DOI] [PubMed] [Google Scholar]
  • 34.Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331–40. doi: 10.1016/S0092-8674(00)80213-5. [DOI] [PubMed] [Google Scholar]
  • 35.Sakai J., Rawson R.B., Espenshade P.J., Cheng D., Seegmiller A.C., Goldstein J.L., Brown M.S. Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells. Mol. Cell. 1998;2:505–14. doi: 10.1016/S1097-2765(00)80150-1. [DOI] [PubMed] [Google Scholar]
  • 36.Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D., and Weisgraber, K.H.: Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem., 262:14352–60, 1987a. [PubMed]
  • 37.Kutt H., Herz J., Stanley K.K. Structure of the low-density lipoprotein receptor-related protein (LRP) promoter. Biochim. Biophys. Acta. 1989;1009:229–36. doi: 10.1016/0167-4781(89)90107-3. [DOI] [PubMed] [Google Scholar]
  • 38.Bu, G., Sun, Y., Schwartz, A.L., and Holtzman, D.M.: Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J. Biol. Chem., 273:13359–65, 1998. [DOI] [PubMed]
  • 39.LaMarre J., Wolf B.B., Kittler E.L., Quesenberry P.J., Gonias S.L. Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. J. Clin. Invest. 1993;91:1219–24. doi: 10.1172/JCI116283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Jokinen, E.V., Landschulz, K.I., Wyne, K.L., Ho, Y.K., Frykman, P.K., and Hobbs, H.H.: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem., 269:26411–8, 1994. [PubMed]
  • 41.Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP) Annu. Rev. Biochem. 1994;63:601–37. doi: 10.1146/annurev.bi.63.070194.003125. [DOI] [PubMed] [Google Scholar]
  • 42.Isobe I., Michikawa M., Yanagisawa K. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid β-protein and chloroquine. Neurosci. Lett. 1999;266:129–132. doi: 10.1016/S0304-3940(99)00282-7. [DOI] [PubMed] [Google Scholar]
  • 43.Sakurai Y., Nishimura D., Yoshimura K., Tsuruo Y., Seiwa C., Asou H. Differentiation of oligodendrocyte occurs in contact with astrocyte. J. Neurosci. Res. 1998;52:17–26. doi: 10.1002/(SICI)1097-4547(19980401)52:1<17::AID-JNR3>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  • 44.Sommer I., Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 1981;83:311–27. doi: 10.1016/0012-1606(81)90477-2. [DOI] [PubMed] [Google Scholar]
  • 45.Fan Q.W., Yuasa S., Kuno N., Senda T., Kobayashi M., Muramatsu T., Kadomatsu K. Expression of basigin, a member of the immunoglobulin superfamily, in the mouse central nervous system. Neurosci. Res. 1998;30:53–63. doi: 10.1016/S0168-0102(97)00119-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the American Aging Association are provided here courtesy of American Aging Association

RESOURCES